VEON vs SPCB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

VEON

34.7
AI Score
VS
SPCB Wins

SPCB

54.5
AI Score

Investment Advisor Scores

VEON

35score
Recommendation
EXTENDED

SPCB

55score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric VEON SPCB Winner
Forward P/E 7.9239 35.2113 VEON
PEG Ratio 2.2274 0 Tie
Revenue Growth 16.9% 13.3% VEON
Earnings Growth -78.9% -14.8% SPCB
Tradestie Score 34.7/100 54.5/100 SPCB
Profit Margin 1.2% 2.9% SPCB
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED STRONG BUY SPCB

Relative Price Performance (Last 90 Days)

VEON 1M: +14.4% · 3M: +60.6% SPCB 1M: -1.7% · 3M: -15.5%

Current Technical Phase

VEON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (16.4% over 20 days), RSI 66

RSI (14): 66.5 · Price: $83.01

SPCB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.2 · Price: $9.31

Fundamentals Snapshot

Metric VEON SPCB
Market Cap — —
Forward P/E 10.0 8.3
Trailing P/E 100.3 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.1%
Gross Margin 0.9% 0.6%
Operating Margin 0.3% 0.1%
EPS 0.79 -0.13
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SPCB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.